A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Clinical trial NCT06411899 · COMPLETED
Trial details
- NCT number
- NCT06411899
- Sponsor
- MoonLake Immunotherapeutics AG
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-15
- Primary completion
- 2025-09-02
- Enrollment
- 422
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.